The “Cairo 24” website published a document of approval by the Egyptian Ministry of Health to use a specific health protocol to conduct clinical trials that include the use of Sovaldi on patients with the Corona virus.
The document, which was published by “Cairo 24”, confirmed the approval of the Ministry of Health for the use of Dr. Sherif Abbas, the doctor accused of causing the death of the journalist Wael Al-Ibrashi, a procedure that provides for clinical trials that include the use of Sovaldi on patients with the Corona virus, as the document stipulated the approval of the Scientific Research Ethics Committee at the Ministry Health and Population and its confirmation of fulfillment of the requirement by a specialized scientific committee on July 5, 2020, and its discussion of scientific research: “Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial” (see document image click here).
The scientific research itself was also recorded, as it appears on a specialized scientific website in your name “Wiley Online Library”, on August 11, 2021, that is, approximately 5 months ago from now, while the approval of the Scientific Research Ethics Committee at the Ministry of Health and Population was approximately a year before that. And 5 months before using the same treatment on the media, Wael Al-Ibrashi, in December of the same year.
And whether this was the same experiment that was applied to Al-Ibrashi, Sherif Abbas explained to “Cairo 24” that it was “the same experience of using Sovaldi on the media, Wael Al-Ibrashi, while the latter knew the use of Sovaldi drug for his treatment before entering the hospital, specifically on December 25, 2020. , after confirming that he was infected with the virus,” noting that “Al-Ibrashi then entered the Sheikh Zayed Specialized Hospital on the 28th of the same month, as a result of the deterioration of his health condition, which was represented by a severe lung crisis, and that Sovaldi had no effects on the lung in the first place, but rather This was a health crisis that he knew before the start of using Sovaldi in the first place, as one of the consequences of infection with the Corona virus.”
And the “Cairo 24” website indicated, according to what it obtained from documents about the same scientific research, that “it was applied in clinical trials to about 120 patients infected with the Corona virus with moderate and severe infection, using the antiviral drug Sovaldi, and its feasibility was calculated in several days of 7 to 10, where it was discovered on the seventh day that oxygen saturation improved significantly, and the study also showed positive trends regarding the effectiveness of the drug with a decrease in mortality.”
It was the death of the Egyptian journalist Wael Al-Ibrashi has sparked widespread controversy, amid accusations against those responsible for his treatment, including Dr. Sherif Abbas, the author of the study.
Source: “Cairo 24”